In the quest to outshine the broader market, stock pickers diligently seek out stocks with the potential for superior performance. Making the right choices can significantly elevate your wealth.
The price of Kymera Therapeutics Inc (NASDAQ: KYMR) closed at $42.30 in the last session, down -1.76% from day before closing price of $43.06. In other words, the price has decreased by -$1.76 from its previous closing price. On the day, 0.58 million shares were traded. KYMR stock price reached its highest trading level at $43.45 during the session, while it also had its lowest trading level at $41.68.
Ratios:
We take a closer look at KYMR’s different ratios to gain a better understanding of the stock. For the most recent quarter (mrq), Quick Ratio is recorded 8.55 and its Current Ratio is at 8.55. In the meantime, Its Debt-to-Equity ratio is 0.10 whereas as Long-Term Debt/Eq ratio is at 0.08.
Upgrades & Downgrades
In addition, analysts’ ratings and any changes thereto give investors an idea of the stock’s future direction. In the most recent recommendation for this company, BTIG Research on December 10, 2024, initiated with a Buy rating and assigned the stock a target price of $60.
On December 06, 2024, BMO Capital Markets started tracking the stock assigning a Market Perform rating and target price of $55.
Wells Fargo Upgraded its Equal Weight to Overweight on December 02, 2024, while the target price for the stock was maintained at $57.
Insider Transactions:
An investor can also benefit from insider trades by learning what management is thinking about the future direction of stock prices. A recent insider transaction in this stock occurred on Dec 02 ’24 when Esposito Pamela sold 2,500 shares for $49.00 per share. The transaction valued at 122,500 led to the insider holds 0 shares of the business.
PAMELA ESPOSITO bought 2,500 shares of KYMR for $117,125 on Dec 02 ’24. On Sep 17 ’24, another insider, Esposito Pamela, who serves as the Director of the company, sold 13,500 shares for $48.28 each. As a result, the insider received 651,766 and left with 0 shares of the company.
Valuation Measures:
Investors should consider key stock statistics when deciding whether to invest or divest. In the wake of the recent closing price, KYMR now has a Market Capitalization of 2739572224 and an Enterprise Value of 2277832192. For the stock, the TTM Price-to-Sale (P/S) ratio is 31.29 while its Price-to-Book (P/B) ratio in mrq is 3.07. Its current Enterprise Value per Revenue stands at 26.014 whereas that against EBITDA is -11.958.
Stock Price History:
Over the past 52 weeks, KYMR has reached a high of $53.27, while it has fallen to a 52-week low of $22.35. The 50-Day Moving Average of the stock is -8.37%, while the 200-Day Moving Average is calculated to be 2.27%.
Shares Statistics:
According to the various share statistics, KYMR traded on average about 441.14K shares per day over the past 3-months and 432970 shares per day over the past 10 days. A total of 64.75M shares are outstanding, with a floating share count of 55.01M. Insiders hold about 15.07% of the company’s shares, while institutions hold 93.75% stake in the company. Shares short for KYMR as of 1732838400 were 9018560 with a Short Ratio of 20.44, compared to 1730332800 on 9161272. Therefore, it implies a Short% of Shares Outstanding of 9018560 and a Short% of Float of 15.55.
